Medeon Biodesign Statistics

Total Valuation

TPEX:6499 has a market cap or net worth of TWD 4.11 billion. The enterprise value is 3.09 billion.

Market Cap	4.11B
Enterprise Value	3.09B

Important Dates

The last earnings date was Thursday, March 6, 2025.

Earnings Date	Mar 6, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:6499 has 92.14 million shares outstanding. The number of shares has increased by 0.11% in one year.

Current Share Class	n/a
Shares Outstanding	92.14M
Shares Change (YoY)	+0.11%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	12.30%
Owned by Institutions (%)	3.50%
Float	46.48M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	14.05
PB Ratio	2.71
P/TBV Ratio	3.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-3.84
EV / Sales	10.56
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.41

Financial Position

The company has a current ratio of 6.11, with a Debt / Equity ratio of 0.11.

Current Ratio	6.11
Quick Ratio	5.81
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	-0.19
Interest Coverage	-159.43

Financial Efficiency

Return on equity (ROE) is -44.56% and return on invested capital (ROIC) is -25.97%.

Return on Equity (ROE)	-44.56%
Return on Assets (ROA)	-23.94%
Return on Invested Capital (ROIC)	-25.97%
Return on Capital Employed (ROCE)	-53.28%
Revenue Per Employee	7.51M
Profits Per Employee	-20.65M
Employee Count	39
Asset Turnover	0.13
Inventory Turnover	9.33

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.36% in the last 52 weeks. The beta is 0.53, so TPEX:6499's price volatility has been lower than the market average.

Beta (5Y)	0.53
52-Week Price Change	+1.36%
50-Day Moving Average	42.47
200-Day Moving Average	44.09
Relative Strength Index (RSI)	49.28
Average Volume (20 Days)	195,591

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6499 had revenue of TWD 292.81 million and -805.51 million in losses. Loss per share was -8.74.

Revenue	292.81M
Gross Profit	83.41M
Operating Income	-885.61M
Pretax Income	-858.64M
Net Income	-805.51M
EBITDA	-839.21M
EBIT	-885.61M
Loss Per Share	-8.74

Full Income Statement

Balance Sheet

The company has 1.21 billion in cash and 168.40 million in debt, giving a net cash position of 1.04 billion or 11.27 per share.

Cash & Cash Equivalents	1.21B
Total Debt	168.40M
Net Cash	1.04B
Net Cash Per Share	11.27
Equity (Book Value)	1.54B
Book Value Per Share	16.50
Working Capital	1.10B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -832.67 million and capital expenditures -74.30 million, giving a free cash flow of -906.97 million.

Operating Cash Flow	-832.67M
Capital Expenditures	-74.30M
Free Cash Flow	-906.97M
FCF Per Share	-9.84

Full Cash Flow Statement

Margins

Gross margin is 28.49%, with operating and profit margins of -302.46% and -275.10%.

Gross Margin	28.49%
Operating Margin	-302.46%
Pretax Margin	-293.24%
Profit Margin	-275.10%
EBITDA Margin	-286.61%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TPEX:6499 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.11%
Shareholder Yield	-0.11%
Earnings Yield	-19.58%
FCF Yield	-22.04%

Dividend Details

Stock Splits

The last stock split was on August 23, 2023. It was a forward split with a ratio of 1.049992864.

Last Split Date	Aug 23, 2023
Split Type	Forward
Split Ratio	1.049992864

Scores

TPEX:6499 has an Altman Z-Score of 5.9.

Altman Z-Score	5.9
Piotroski F-Score	n/a